|
|
Understanding DED and Treatments on the Horizon
This panel of experts in ocular surface diseases reviews the changing approach to managing patients with dry eye based on the latest research and their clinical experience. The panel members also discuss pipeline therapies and how they may compare to current treatments.
This certified CE activity is designed for optometrists. |
|
|
Evolving Concepts in Anterior Segment Outcomes: Identifying New Treatments for Keratoconus Video Interview
In this video interview, Gloria B. Chiu, OD, FAAO, FSLS, discusses the diagnosis and treatment of early and mild keratoconus, including the use of corneal crosslinking in the management of these patients.
|
|
|
Evolving Concepts in Anterior Segment Outcomes: Comanaging Premium IOL Patients Video Interview
In this video interview, Marc Bloomenstein, OD and Justin Schweitzer, OD discuss comanaging premium intraocular lens patients. How do you talk to patients about presbyopia-correcting and toric IOLs before surgery? What instruments do you rely on to accurately assess preoperative patients? How do you handle difficult patients? How do you address postoperative residual astigmatism? Watch this video to find out!
|
|
|
Evolving Concepts in Anterior Segment Outcomes: Tackling Ocular Surface Disease Video Interview
In this video interview, Douglas K. Devries, OD, discusses the negative impact of undiagnosed and untreated ocular surface disease. He give pearls for comanaging cataract surgery patients, screening for meibomian gland dysfunction, and approaching OSD management in patients with comorbid conditions.
|
|
|
Cataract Surgery: Discussions on Post-Operative Ocular Inflammation
Despite the routine use of antibiotics, corticosteroids, and nonsteroidal anti-inflammatory (NSAID) agents in postoperative ophthalmic surgical care, there remain issues with drug delivery of these agents. Ongoing education about novel corticosteroids and technologies is warranted to ensure eye care providers can deliver the best patient care possible.
All education activities identified in this education design document will be targeted to ophthalmologists and optometrists. The following c... |
|
|
MIGS: Managing Post-Operative Inflammation
Despite the routine use of antibiotics, corticosteroids, and nonsteroidal anti-inflammatory (NSAID) agents in postoperative ophthalmic surgical care, there remain issues with drug delivery of these agents. Ongoing education about novel corticosteroids and technologies is warranted to ensure eye care providers can deliver the best patient care possible.
All education activities identified in this education design document will be targeted to ophthalmologists and optometrists. The following cat... |
|
|
PHARMACOLOGICAL PRESBYOPIA TREATMENT CONSENSUS STATEMENT: CLINICAL RECOMMENDATIONS FOR TODAY’S PRESBYOPIA PATIENT
This supplement, captured from a delphi panel of expert key opinion leaders, provides consensus recommendations related to defining, diagnosing, and pharmacologically treating presbyopia.
This certified CME/CE activity is designed for optometrists and ophthalmologists who care for patients with presbyopia.
|
|
|
Cataract-Refractive Surgery: Longer Duration Therapies for Postoperative Pain and Inflammation
Despite the routine use of antibiotics, corticosteroids, and nonsteroidal anti-inflammatory (NSAID) agents in postoperative ophthalmic surgical care, there remain issues with drug delivery of these agents. Ongoing education about novel corticosteroids and technologies is warranted to ensure eye care providers can deliver the best patient care possible.
All education activities identified in this education design document will be targeted to ophthalmologists and optometrists. The following c... |
|
|
Diabetic Retinopathy Update: Best Practices in Referrals, Screening, and Treatments
This continuing education activity captures content from a virtual roundtable discussion.
ACTIVITY DESCRIPTION
The overwhelming majority (85%) of comprehensive eye exams are conducted by optometrists. Diabetic retinopathy (DR) is the most common ocular complication of diabetes and is currently responsible for more than 10,000 new cases of blindness each year in the United States alone. This supplement highlights discussion topics among experts in the field and provides important education ... |
|
|
Adapting to Change: Incorporating Telemedicine into Our Practice - For the Optometrist
Although telemedicine is not new to ophthalmology, the 2020 coronavirus pandemic has heightened the need for options that keep patients and eye care providers safe. Eye care providers need to be educated on the changing regulations related to office visits and billing, the enhanced safety measures required, and the ocular conditions best suited for telemedicine. |
|
|
Addressing Barriers to Prompt, Early Treatment for Diabetic Retinopathy and Diabetic Macular Edema
Diabetic retinopathy (DR) is typically asymptomatic in its early stages. Therefore, best practice guidelines recommend people with diabetes have annual eye exams to screen for DR, nonproliferative DR, and diabetic macular edema to allow for early detection and timely treatment.
This virtual symposia hosted by Dr. Dilsher Dhoot is designed to foster collaboration in provider networks and encourage discussions on the latest trial data and clinical experience related to the importance of imagi... |
|
|
Imaging and Preoperative Evaluations
This series of six webcasts offers insight on various issues that are important to eye care professionals.
Each of the webcasts features individualized content, including how to run an efficient practice while caring for patients in the COVID-19 era; use of high-quality screening, monitoring and imaging devices across eye care subspecialties; thorough discussions on why connectivity and transfer of preoperative data to intraoperative technology is necessary for optimal visual outcomes; and ... |
|
|
DED: Two Sides of One Disease
This webinar brings together three experts in the diagnosis and treatment of patients with dry eye disease (DED). Marc R. Bloomenstein, OD, FAAO, Selina R. McGee, OD, FAAO, DIPL ABO, and Leslie O’Dell, OD, FAAO, will discuss how DED can present as both an acute and a chronic disease and will also review the latest data on emerging therapies. |
|
|
KERATOCONUS TESTING CONSENSUS STATEMENT: Understanding the Incidence and Impact of Keratoconus in Corneal Refractive Surgery & Reviewing New Standards to Preemptively Identify These Patients
World class leaders assembled to discuss and vote on best practices and guidelines for understanding the incidence and impact of keratoconus in corneal refractive surgery and reviewing new standards to preemptively identify these patients. Topics of discussion included defining the fundamental etiology and progression of keratoconus, identifying the prevalence and demographics of keratoconus in various patient populations, diagnosing keratoconus and the importance of early detection using gene... |
|
|
Practice Strategies and Imaging in the COVID Era
This is part of a series of six webcasts that offer insight into topics that are important to eye care professionals in various subspecialties.
The COVID-19 pandemic is continuing its global impact. In this webcast, two retina specialists discuss the ways they have adapted their practices and strategies for caring for patients while keeping their physicians and staff members safe. Also discussed is the key role of OCT imaging in retina practices and how the pandemic may generate innovative ... |
|
|
Refractive Surgery: Modern Methods
This series of six webcasts offers insight on various issues that are important to eye care professionals.
Each of the webcasts features individualized content, including how to run an efficient practice while caring for patients in the COVID-19 era; use of high-quality screening, monitoring and imaging devices across eye care subspecialties; thorough discussions on why connectivity and transfer of preoperative data to intraoperative technology is necessary for optimal visual outcomes; and ... |
|
|
Laser Refractive Surgery Options: How Do We Choose?
This series of six webcasts offers insight on various issues that are important to eye care professionals.
Each of the webcasts features individualized content, including how to run an efficient practice while caring for patients in the COVID-19 era; use of high-quality screening, monitoring and imaging devices across eye care subspecialties; thorough discussions on why connectivity and transfer of preoperative data to intraoperative technology is necessary for optimal visual outcomes; and ... |
|
|
Glaucoma: Current Strategies for Detecting Disease Progression
This is part of a series of six webcasts that offer insight into topics that are important to eye care professionals in various subspecialties.
Focusing specifically on glaucoma management, two experts in the field share their expertise and advise how to optimize the way patients are monitored over time to detect disease progression. The importance of optic disc photos and OCT imaging, in addition to visual field progression and OCT progression will also be discussed, along with clinical ca... |
|
|
Targeting the Trabecular Meshwork: Incorporating New Outflow Drugs Into Glaucoma Care
Glaucoma is seeing a resurgence in innovative therapeutic developments. The recent approval of two drugs in novel classes for IOP reduction in eyes with ocular hypertension or open-angle glaucoma utilizes unique mechanisms of action not previously available with existing drug choices. This activity will provide education on the efficacy, safety, and mechanism of action of these two new drugs and how they compare to traditional glaucoma treatments. |
|
|
The Role of the Optometrist in the Evolving Management of Diabetic Retinopathy
The content featured in this supplement highlights the crucial role that optometrists play in educating patients with diabetes about the potential ocular complications of their systemic disorder, the additional care that must be addressed when undergoing ocular surgery (ie, cataract), and the benefits of diabetic eye exams and early treatment.
|
|
|
Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease"Preparing for an Updated Armamentarium
Target Audience
This online activity is targeted to practitioners who are involved in treating patients with MGD-associated DED, such as optometrists, ophthalmologists, nurse practitioners, physician assistants, and nurses.
Activity Overview
Meibomian gland dysfunction (MGD) is one of the most common causes of dry eye disease (DED), which can profoundly impact patients and their quality of life. Although many treatment options are available, no pharmacologic treatment has yet been app... |
|
|
Exploring Emerging Trends in Medical Glaucoma Management
This webinar focuses on the newest therapies in glaucoma management and how their mechanisms of action and efficacy compares to traditional prostaglandins. The webinar also includes case discussions. |
|
|
Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases
Target Audience
This educational activity is directed towards comprehensive ophthalmologists, retinal specialists, optometrists, and other health care professionals involved in the treatment of patients with retinal diseases.
Program Overview
This Expert Illustrations and Commentaries™ is a video-based program in which 2 experts discuss the etiology and management of diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD). In this activity, the faculty f... |
|
|
Targeting the Trabecular Meshwork: Collaborative Glaucoma Care
This supplement focuses on the comanagement of patients with glaucoma, specifically those who may be candidates for microinvasive glaucoma surgery procedures (MIGS) that target the trabecular meshwork, and the ways in which optometrists and ophthalmologists collaborate to provide the best pre- and postoperative care for these patients. |
|
|
Splendors of Southern Europe Cruise: Exploring Medicine, Dentistry & the Mediterranean Healthcare Model
Exploring Medicine, Dentistry & the Mediterranean Healthcare Model
CME/CE Lecture Seminars for Medical, Dental, Nursing, and Allied Healthcare Professionals
This Seminar is planned for 12 Continuing Education Credit Hours.
CME/CE Professional Seminar Fee: $695
Seminar Attendance Fee: $450
CME/CE credits, Certificates of Completion and possible tax deductible guidelines will be provided for registered Professional Seminar attendees Certificates of Attendance will be provi... |
|
|
Preparing for the Future: Updates in Retinal Diseases and Novel Therapies
Content Source
This continuing education (CE) activity captures content from a virtual roundtable discussion.
Activity Description
Based on a roundtable discussion in August, this supplement summarizes the challenges facing clinicians when managing diabetic eye disease and wet age-related macular degeneration (AMD) and the current and pipeline therapy options for these diseases.
Target Audience
This certified CE activity is designed for optometrists who care for patients with di... |
|
|
Treating Presbyopia: New Approaches to a Familiar Problem
Content Source
This continuing medical education (CE/CME) activity captures content from a live symposium at ASCRS.
Activity Description
Based on a live symposium held during the American Society for Cataract and Refractive Surgeons Annual Meeting, this supplement summarizes the presentations on how to manage presbyopic changes with a variety of current and newly emerging treatment options, and how strategies may work synergistically.
Target Audience
This certified continuing me... |
|
|
Ocular Manifestations of Infectious Diseases in Children
Since the onset of the COVID-19 pandemic, national vaccination rates have dropped significantly, and there is concern about a potential rise in vaccine-preventable diseases (VPDs), especially in children. As members of the healthcare community, eye care providers should recognize that vaccines are the best way to protect themselves and their families, as well as their patients and coworkers. This webinar focuses on various systemic and ocular presentations of infectious diseases, with a focus ... |
|
|
Modern Medical Glaucoma Exploring the Trends
This webcast focuses on the newest therapies in glaucoma management and how their mechanisms of action and efficacy compares to traditional prostaglandins. The webcast also includes case discussions. Please also enjoy the perviously recorded question-and-answer session with Drs. Ian Benjamin Gaddie and Gagan Sawhney! |
|
|
Community Practice Connections™: Expert Approaches in Cataract Surgery " Managing Advances in Techniques and Technologies With an Updated Armamentarium - COPE
Target Audience
This online educational activity is directed toward ophthalmologists and other health care professionals involved in the management of patients with cataracts.
Activity Overview
Surgical removal of cataracts and implantation with intraocular lenses (IOLs) is an increasingly common procedure. The growing variety of pre- and intraoperative surgical devices and IOLs is expanding options for both patients and clinicians. Appropriate technique and IOL selection for each patient... |
|
|
MGD-Associated Dry Eye Disease " How Emerging Options May Shift the Treatment Paradigm (COPE)
Target Audience
The target audience for this activity is optometrists and other health care professionals who are involved in the management of patients with MGD-associated DED.
Activity Overview
Meibomian gland dysfunction (MGD) is a complex, multifactorial disorder that can lead to altered tear film composition and ocular surface disease. In fact, MGD is one of the most common causes of dry eye disease (DED). Although multiple treatment options are available, therapies that target the u... |
|
|
Neurotrophic Keratitis: Managing a Sensitive Issue
Neurotrophic keratitis (NK) is a rare degenerative corneal disease that if left untreated can lead to infection, ulceration, stromal melting, perforation secondary to poor healing, and vision loss. Patients with early stages of NK may experience few symptoms, which makes diagnosis challenging and potentially puts them at risk for epithelial damage, as seen in later stages of disease. Testing to evaluate reduced corneal sensitivity and nerve damage is imperative in diagnosing NK. Current and em... |
|
|
Expert Illustrations & Commentaries™: Visualizing Cornea l Innervation, Pathophysiology, and Treatment Mechanisms in Neurotrophic Keratitis
Target Audience
This educational activity is directed toward ophthalmologists, optometrists, and other health care professionals who would be involved in treating NK.
Program Overview
This video-based program is designed for health care professionals to explore the diagnosis and treatment of neurotropic keratitis (NK) through a unique perspective, putting the patient voice front and center. A patient with NK will share her experiences. Expert faculty will share commentary on NK etiolo... |
|
|
Expert Illustrations & Commentaries™: Visualizing Cornea l Innervation, Pathophysiology, and Treatment Mechanisms in Neurotrophic Keratitis
Target Audience
This educational activity is directed toward ophthalmologists, optometrists, and other health care professionals who would be involved in treating NK.
Program Overview
This video-based program is designed for health care professionals to explore the diagnosis and treatment of neurotropic keratitis (NK) through a unique perspective, putting the patient voice front and center. A patient with NK will share her experiences. Expert faculty will share commentary on NK etiolo... |
|
|
Uveitic Macular Edema: Assessing Diagnostic Patterns and Treatment Options That Can Keep This Complication Out of Sight
Inflammation of the uvea"or uveitis"is conducive to about 10% of blindness in people in the United States. Approximately 80% of uveitis is noninfectious in etiology, imposing a substantial socioeconomic impact to affected patients and the US health care system every year. A prominent complication is uveitic macular edema (UME), which affects up to 30% of all patients regardless of etiology and is the leading cause of blindness in patients with uveitis. Establishing the correct diagno... |
|
|
Stump the Provider: A 27-Year-Old Man With Blurred Vision in the Right Eye
In this article, Dr. Jeng reviews approaches to diagnosis and management of ocular surface disease in a contact lens wearer experiencing blurred vision. |
|
|
Evidence-Based Approaches to Diagnose, Treat, and Manage Patients With Retinal Diseases: Summaries of Clinical Trials
Therapeutic and surgical algorithms for the management and treatment of patients with retinal diseases continue to evolve, while management protocols are being further refined in light of real-world outcomes. Recognizing and understanding these evidence-based treatment advances are imperative to enhance treatment outcomes; however, staying up-to-date with the latest evidence from clinical trials as well as emerging diagnostic and treatment options can be challenging. To address these ongoing n... |
|
|
Evidence-Based Approaches to Diagnose, Treat, and Manage Patients With Retinal Diseases: Summaries of Clinical Trials
Therapeutic and surgical algorithms for the management and treatment of patients with retinal diseases continue to evolve, while management protocols are being further refined in light of real-world outcomes. Recognizing and understanding these evidence-based treatment advances are imperative to enhance treatment outcomes; however, staying up-to-date with the latest evidence from clinical trials as well as emerging diagnostic and treatment options can be challenging. To address these ongoing n... |
|
|
Evidence-Based Approaches to Diagnose, Treat, and Manage Patients With Retinal Diseases: Summaries of Clinical Trials
Therapeutic and surgical algorithms for the management and treatment of patients with retinal diseases continue to evolve, while management protocols are being further refined in light of real-world outcomes. Recognizing and understanding these evidence-based treatment advances are imperative to enhance treatment outcomes; however, staying up-to-date with the latest evidence from clinical trials as well as emerging diagnostic and treatment options can be challenging. To address these ongoing n... |
|
|
Evidence-Based Approaches to Diagnose, Treat, and Manage Patients With Retinal Diseases: Summaries of Clinical Trials
Therapeutic and surgical algorithms for the management and treatment of patients with retinal diseases continue to evolve, while management protocols are being further refined in light of real-world outcomes. Recognizing and understanding these evidence-based treatment advances are imperative to enhance treatment outcomes; however, staying up-to-date with the latest evidence from clinical trials as well as emerging diagnostic and treatment options can be challenging. To address these ongoing n... |
|
|
Real World Retina: Challenges in the Management of Retinal Disease - Focus on Age-related Macular Degeneration
Real-world outcomes of patients with retinal diseases treated with intravitreal anti-vascular endothelial growth factor (VEGF) therapies are often suboptimal when compared to the results demonstrated in pinnacle clinical studies. The discrepancies in outcomes have in part been attributed to patients receiving fewer than the recommended number of anti-VEGF injections, as well as patients discontinuing therapy due to treatment burden associated with frequent dosing schedules. New imaging techniq... |
|
|
Real World Retina: Challenges in the Management of Retinal Disease - Focus on Diabetic Retinopathy
Real-world outcomes of patients with retinal diseases treated with intravitreal anti-vascular endothelial growth factor (VEGF) therapies are often suboptimal when compared to the results demonstrated in pinnacle clinical studies. The discrepancies in outcomes have in part been attributed to patients receiving fewer than the recommended number of anti-VEGF injections, as well as patients discontinuing therapy due to treatment burden associated with frequent dosing schedules. New imaging techniq... |
|
|
Real World Retina: Challenges in the Management of Retinal Disease " Focus on Diabetic Macular Edema
Real-world outcomes of patients with retinal diseases treated with intravitreal anti-vascular endothelial growth factor (VEGF) therapies are often suboptimal when compared to the results demonstrated in pinnacle clinical studies. The discrepancies in outcomes have in part been attributed to patients receiving fewer than the recommended number of anti-VEGF injections, as well as patients discontinuing therapy due to treatment burden associated with frequent dosing schedules. New imaging techniq... |
|
|
Real World Retina: Challenges in the Management of Retinal Disease " Focus on Retinal Vein Occlusion
Real-world outcomes of patients with retinal diseases treated with intravitreal anti-vascular endothelial growth factor (VEGF) therapies are often suboptimal when compared to the results demonstrated in pinnacle clinical studies. The discrepancies in outcomes have in part been attributed to patients receiving fewer than the recommended number of anti-VEGF injections, as well as patients discontinuing therapy due to treatment burden associated with frequent dosing schedules. New imaging techniq... |
|
|
Thyroid Eye Disease: Addressing the Need for Early Intervention and Comanagement
Thyroid eye disease (TED) is a multifactorial, autoimmune disorder with a wide spectrum of signs and symptoms. It is frequently misdiagnosed, due to both the heterogeneous clinical presentation and a failure on the part of clinicians to understand the relationship between TED and hyperthyroidism. Misdiagnosis can place patients at increased risk for complications; however, a differential diagnosis can be achieved with the assistance of imaging. Early diagnosis and treatment can limit disfigure... |
|
|
A Practical Roadmap for Diagnosing and Treating DED, With Drs. Lisa Nijm and Vance Thompson
In this educational podcast, faculty lay out a practical road map for diagnosing and treating dry eye disease using the currently available diagnostic tools and therapeutics. |
|
|
In Case You Missed: Advancing Science in the Management of Demodex Blepharitis
Recent US studies have reported Demodex blepharitis infestation rates of 55% to 58% in eye care clinical patients. However, patients with Demodex blepharitis may go undiagnosed or misdiagnosed due to overlapping symptoms seen in dry eye disease and other ocular surface or lid margin disorders. Treatment can also be challenging as there are currently no FDA-approved therapies and most conventional options treat the symptoms of disease but not the underlying cause. Emerging therapeutic options a... |
|
|
Surgical Solutions to Achieve and Maintain Visual Gains in nAMD
Management of patients with retinal vascular diseases utilizing intravitreal anti-vascular endothelial growth factor (VEGF) therapy has provided significant enhancements to visual acuity outcomes, but maintenance of these visual acuity gains requires frequent treatment and monitoring. The frequency of these clinical visits can be a challenge to sustain and places a considerable burden on the patient and caregivers―often resulting in undertreatment of disease due to loss of adherence. To addr... |
|
|
Surgical Solutions to Achieve and Maintain Visual Gains in nAMD
Management of patients with retinal vascular diseases utilizing intravitreal anti-vascular endothelial growth factor (VEGF) therapy has provided significant enhancements to visual acuity outcomes, but maintenance of these visual acuity gains requires frequent treatment and monitoring. The frequency of these clinical visits can be a challenge to sustain and places a considerable burden on the patient and caregivers―often resulting in undertreatment of disease due to loss of adherence. To addr... |
|
|
Extending the Span of Time in nAMD and DME Management
Intravitreal anti-vascular endothelial growth factor (VEGF) therapies have significantly enhanced visual and anatomical outcomes for patients with diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD). However, real-world outcomes are not always comparable to those demonstrated in pinnacle clinical studies, in part due to treatment burden and lack of patient adherence. Corticosteroids are another effective therapeutic option for those patients with DME, but these... |
|